| ISIN | LU1871077506 |
|---|---|
| Valor Number | 43375930 |
| Bloomberg Global ID | CSEQEDB LX |
| Fund Name | UBS (Lux) Fund Solutions II - UBS MSCI Europe Index Fund EUR I-B acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | Equity Europe |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The Subfund tracks the MSCI Europe Index as its benchmark index. The Investment Objective of the Subfund is to provide the Shareholders with a return in line with the performance of the MSCI Europe Index (the “Underlying Index”) (see description under the section “Description of the Underlying Index”). |
| Peculiarities |
| Current Price * | 2,002.01 EUR | 06.11.2025 |
|---|---|---|
| Previous Price * | 2,015.05 EUR | 05.11.2025 |
| 52 Week High * | 2,030.41 EUR | 27.10.2025 |
| 52 Week Low * | 1,626.43 EUR | 09.04.2025 |
| NAV * | 2,002.01 EUR | 06.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 128,096,050 | |
| Unit/Share Assets *** | 104,954,896 | |
| Trading Information SIX | ||
| YTD Performance | +14.99% |
31.12.2024 - 06.11.2025
31.12.2024 06.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +14.01% |
31.12.2024 - 06.11.2025
31.12.2024 06.11.2025 |
| 1 month | -0.28% |
06.10.2025 - 06.11.2025
06.10.2025 06.11.2025 |
| 3 months | +5.78% |
06.08.2025 - 06.11.2025
06.08.2025 06.11.2025 |
| 6 months | +7.32% |
06.05.2025 - 06.11.2025
06.05.2025 06.11.2025 |
| 1 year | +15.39% |
06.11.2024 - 06.11.2025
06.11.2024 06.11.2025 |
| 2 years | +35.26% |
06.11.2023 - 06.11.2025
06.11.2023 06.11.2025 |
| 3 years | +48.01% |
07.11.2022 - 06.11.2025
07.11.2022 06.11.2025 |
| 5 years | +81.19% |
06.11.2020 - 06.11.2025
06.11.2020 06.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAP SE | 2.51% | |
|---|---|---|
| Nestle SA | 2.34% | |
| ASML Holding NV | 2.18% | |
| Roche Holding AG | 1.93% | |
| Novartis AG Registered Shares | 1.88% | |
| AstraZeneca PLC | 1.86% | |
| Novo Nordisk AS Class B | 1.80% | |
| HSBC Holdings PLC | 1.68% | |
| Shell PLC | 1.68% | |
| Siemens AG | 1.45% | |
| Last data update | 30.04.2025 | |
| TER | 0.02% |
|---|---|
| TER date | 31.12.2024 |
| Performance Fee *** | 0.00% |
| PTR | |
| Max. Management Fee *** | 0.02% |
| Ongoing Charges *** | 0.02% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |